|
Rigel soars on favorable allergy drug data
|
| NEW YORK, Aug 2 (Reuters) - Rigel Pharmaceuticals Inc. (RIGL.O: Quote, Profile, Research) on Monday said its experimental allergy drug "dramatically" relieved symptoms in a mid-stage trial, sending its shares up as much as 48 percent. |
|
| Updated |
Aug 3, 2004 01:07:03 |
| Rating |
0 | | Author | Reuters |
|
|
| Other author's news: | - TV, Online Units Fuel Playboy Profit - Playboy Enterprises Inc. onWednesday reported a better-than-expected quarterly net profit,helped by strength at its television and online operations thatovercame lower results at its flagship magazine.
- Barclays first half profit rise boosts shares - British bank Barclays Plc postedfirst-half profit ahead of forecasts on Friday as revenuegrowth more than made up for rising bad debt charges, sendingits shares up.
- Credit Suisse to Integrate Units - Credit Suisse will fully integrate itsinvestment bank Credit Suisse First Boston with the rest of itsbanking business, the Swiss group said on Tuesday, as it setambitious earnings targets for 2007.
| | Show all author's news |
| Similar news: | - A Catfight over Allergy-Free Kitties - Would-be cat lovers with severe allergies to felines may one day get to indulge their passion if researchers have their way. Two upstart companies -- Transgenic Pets and Allerca -- are attempting to apply to cats the same basic methods of genetic manipula
- New drugs help Eli Lilly sales soar 15 percent - Eli Lilly and Co. displayed the power of its vaunted drug-development pipeline Thursday with a 15 percent increase in sales in the second quarter, powered -- in part -- by six drugs that have come on the market in the past 21/2 years.
- IMF says Czech economic outlook 'favorable' - WASHINGTON, Aug 17 (Reuters) - The International Monetary Fund said on Tuesday the near-term economic outlook for the Czech Republic, a European Union newcomer, was favorable with growth expected to strengthen.
| | Find all news similar on Rigel soars on favorable allergy drug data |
|
